0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08402153 2022-04-01 2023-03-31 08402153 2023-03-31 08402153 2022-03-31 08402153 2021-04-01 2022-03-31 08402153 2022-03-31 08402153 2021-03-31 08402153 bus:Director2 2022-04-01 2023-03-31 08402153 core:WithinOneYear 2023-03-31 08402153 core:WithinOneYear 2022-03-31 08402153 core:ShareCapital 2023-03-31 08402153 core:ShareCapital 2022-03-31 08402153 core:RetainedEarningsAccumulatedLosses 2023-03-31 08402153 core:RetainedEarningsAccumulatedLosses 2022-03-31 08402153 bus:SmallEntities 2022-04-01 2023-03-31 08402153 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 08402153 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 08402153 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 08402153 bus:FullAccounts 2022-04-01 2023-03-31
COMPANY REGISTRATION NUMBER: 08402153

Blood Sisters Ltd

Filleted Unaudited Financial Statements

31 March 2023

Blood Sisters Ltd

Statement of Financial Position

31 March 2023

| 2023 | 2022
Note | £ | £ | £

Current assets

Debtors | 5 | 4,266,726 |  | 1,761,145
Cash at bank and in hand | 14,278 |  | 2,085,681
| ------------ |  | ------------
| 4,281,004 |  | 3,846,826

Creditors: amounts falling due within one year | 6 | 1,132,431 |  | 679,975
| ------------ |  | ------------
Net current assets |  | 3,148,573 | 3,166,851
|  | ------------ | ------------
Total assets less current liabilities |  | 3,148,573 | 3,166,851
|  | ------------ | ------------
Net assets |  | 3,148,573 | 3,166,851
|  | ------------ | ------------

Capital and reserves

Called up share capital |  | 100 | 100
Profit and loss account |  | 3,148,473 | 3,166,751
|  | ------------ | ------------
Shareholder funds |  | 3,148,573 | 3,166,851
|  | ------------ | ------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 3 October 2023 , and are signed on behalf of the board by:

Mr. Deepak Nayar |
Director |

Company registration number: 08402153

Blood Sisters Ltd

Notes to the Financial Statements

Year ended 31 March 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 99 Kenton Road, Harrow, Middlesex, HA3 0AN.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost .
4. Particulars of employees
The average number of persons employed by the company during the year amounted to Nil (2022: 1 ).
5. Debtors

| 2023 | 2022
| £ | £
Trade debtors | 3,344 | 3,692
Other debtors | 4,263,382 | 1,757,453
| ------------ | ------------
| 4,266,726 | 1,761,145
| ------------ | ------------

6. Creditors: amounts falling due within one year

| 2023 | 2022
| £ | £
Trade creditors | 15,189 | 6,233
Other creditors - | 1,078,742 | 653,742
Other creditors | 38,500 | 20,000
| ------------ | ---------
| 1,132,431 | 679,975
| ------------ | ---------

7. Controlling party
The company was under the control of Mr Deepak Nayar throughout the period. Mr. Nayar is the managing director and majority shareholder.